Vascular access for continuous renal replacement therapy

Seminars in Dialysis

Volumn 22, Issue 2, 2009, Pages 133-136

  Vijayan, Anitha ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIOVENOUS SHUNT; ARTICLE; FEMORAL VEIN; HUMAN; INDWELLING CATHETER; KIDNEY FAILURE; METHODOLOGY; RENAL REPLACEMENT THERAPY; SUBCLAVIAN VEIN;

ARTERIOVENOUS SHUNT, SURGICAL; CATHETERS, INDWELLING; FEMORAL VEIN; HUMANS; KIDNEY FAILURE; RENAL REPLACEMENT THERAPY; SUBCLAVIAN VEIN;

EID: 65249175694     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2008.00553.x     Document Type: Article

References (13)

1. Lin BS, Kong CW, Tarng DC, Huang TP, Tang GJ : Anatomical variation of the internal jugular vein and its impact on temporary haemodialysis vascular access: an ultrasonographic survey in uraemic patients. Nephrol Dial Transplant 13 : 134 138, 1998
2. Forauer AR, Glockner JF : Importance of US findings in access planning during jugular vein hemodialysis catheter placements. J Vasc Interv Radiol 11 : 233 238, 2000
3. Randolph AG, Cook DJ, Gonzales CA, Pribble CG : Ultrasound guidance for placement of central venous catheters: a meta-analysis of the literature. Crit Care Med 24 : 2053 2058, 1996
4. Karakitsos D, Labropoulos N, De Groot E, Patrianakos AP, Kouraklis G, Poularas J, Samonis G, Tsoutsos DA, Konstadoulakis MM, Karabinis A : Real-time ultrasound-guided catheterisation of the internal jugular vein: a prospective comparison with the landmark technique in critical care patients. Crit Care 10 : R162, 2006
5. Canaud B, Desmeules S, Klouche K, Leray-Moragues H, et al. : Vascular access for dialysis in the intensive care unit. Best Pract Res Clin Anaesthesiol 18 : 159 174, 2004
6. Brzosko S, Hryszko T, Malyszko J, Malyszko JS, Mazerska M, Mysliwiec M : Femoral localization and higher ultrafiltration rate but not concentration of heparin used for canal locking of hemodialysis catheter are negative predictors for its malfunction. Am J Nephrol 28 : 298 303, 2008
7. Daeihagh P, Jordan J, Chen J, Rocco M : Efficacy of tissue plasminogen activator administration on patency of hemodialysis access catheters. Am J Kidney Dis 36 : 75 79, 2000
8. Zacharias JM, Weatherston CP, Spewak CR, Vercaigne LM : Alteplase versus urokinase for occluded hemodialysis catheters. Ann Pharmacother 37 : 27 33, 2003
9. Vascular Access Work Group : Clinical practice guidelines for vascular access. Am J Kidney Dis 48 (Suppl. 1 S248 S273, 2006
10. Parienti JJ, Thirion M, Megarbane B, Souweine B, Ouchikhe A, Polito A, Forel JM, Marque S, Misset B, Airapetian N, Daurel C, Mira JP, Ramakers M, duCheyron D, Le Coutour X, Daubin C, Charbonneau P : Femoral vs. jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA 299 : 2413 2422, 2008
11. Kim SH, Song KI, Chang JW, Kim SB, Sung SA, Jo SK, Cho WY, Kim HK : Prevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique: a prospective, randomized clinical trial. Kidney Int 69 : 161 164, 2006
12. Weijmer MC, van den Dorpel MA, Van de Ven PJ, ter Wee PM, van Geelen JA, Groeneveld JO, van Jaarsveld BC, Koopmans MG, le Poole CY, Schrander-Van der Meer AM, Siegert CE, Stas KJ : Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol 16 : 2769 2777, 2005
13. Allon M : Current management of vascular access. Clin J Am Soc Nephrol 2 : 786 800, 2007